Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Pharmaceutical Industries Ltd (TEVA) - Product Pipeline Analysis, 2021 Update
Medincell stock drops as FDA hits Teva with CRL on long-acting risperidone | BioWorld
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug | Investor's Business Daily
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva's migraine drug Ajovy secures European marketing approval
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva Pharmaceuticals (@TevaUSA) / X
Teva's Key Drugs in Its Specialty Products Pipeline
Teva obtains FDA nod for generic Forteo | Drug Store News
Teva Pharmaceutical: Long-Term Cash Cow
US FDA eases Teva headache with Ajovy approval
Catalyst Pharmaceuticals: Until TEVA ANDA Is Resolved, There Is A Risk | Seeking Alpha
Non-Hodgkin Lymphoma Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | AstraZeneca, Baxter International Inc., Bayer AG, Bristol Myers Squibb, Teva Pharma, Eli Lilly, Roche – ABNewswire
Teva's drug pipeline could contain blockbusters - Globes
Generic NSCLC treatment launched by Teva
EX-99.1
Teva Pharmaceuticals gets FDA approval for Osteoporosis injection | Eric A. Hughes, MD, PhD posted on the topic | LinkedIn
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Celltrion FDA warning causes headache for Teva's biologics ambition
